The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...
Today, Thermo Fisher has a leading portfolio of offerings in cell culture media and single-use technologies. Solventum’s innovative filtration portfolio broadens Thermo Fisher’s capabilities ...
AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing ... The department is focused on offering upstream cell culture, downstream purification ...
The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug disc ...
The factors contributing to the growth of the microcarriers market are rising investments in cell & gene therapy research, ...
Dealbreaker on MSN16d
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz SegmentThermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback